Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now?

Area of Science:

• Pediatric Infectious Diseases
• Immunology
• Vaccinology

Background:

• Respiratory Syncytial Virus (RSV) is a major cause of pediatric hospitalizations globally.
• RSV infection poses a significant healthcare burden worldwide.
• The prefusion F protein is identified as a critical target for RSV immunization.

Purpose of the Study:

• To review past, present, and future research on RSV immunization in children.
• To discuss various immunization approaches including monoclonal antibodies, maternal immunization, and vaccines.
• To address challenges in preventing RSV infections in the pediatric population.

Main Methods:

• Literature review of previous, current, and ongoing research.
• Analysis of different immunization strategies against RSV.
• Discussion of challenges in pediatric RSV prevention.

Main Results:

• Advances in identifying the prefusion F protein as a key immunization target.
• Identification of monoclonal antibodies, maternal immunization, and vaccines as key strategies.
• Acknowledgement of persistent challenges in pediatric RSV prevention.

Conclusions:

• The prefusion F protein is central to effective RSV immunization.
• Multiple immunization strategies are under investigation for pediatric populations.
• Overcoming challenges is crucial for successful RSV prevention in children.